Heier Jeffrey S.
SEC CIK 1653082 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| OCUL | OCULAR THERAPEUTIX, INC | Dir | 318.3K | $45.8K | $349.5K | 14 | 2022-05-12 | 2026-08-24 |
Most active insiders at OCUL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Dugel Pravin | See Remarks, Dir | — | $1.94M |
| 2 | LINDSTROM RICHARD L MD | Dir | $461.4K | — |
| 3 | Saroj Namrata | Chief Business Off | — | $277.8K |
| 4 | Heier Jeffrey S. | CSO | — | $243.3K |
| 5 | Kaiser Peter | Chief Development Off | — | $222.9K |
| 6 | Waheed Nadia | Chief Medical Off | — | $220.9K |
| 7 | Notman Donald | See Remarks | — | $216.1K |
| 8 | Nayak Sanjay | Chief Strategy Off | — | $166.4K |
| 9 | Anderman Todd | CLO | — | $137.4K |
| 10 | Robinson David Wayne | Gbl CCO | — | — |
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-26 17:57 | 2026-08-24 | OCUL | OCULAR THERAPEUTIX, INC | Heier Jeffrey S. | CSO | S - Sale | $10.78 | -3,296 | 318.3K | -1% | -$35.5K |
| T | 2026-05-28 16:06 | 2026-05-26 | OCUL | OCULAR THERAPEUTIX, INC | Heier Jeffrey S. | CSO | S - Sale | $8.20 | -3,018 | 320.4K | -0.9% | -$24.7K |
| 2026-02-25 | 2026-02-23 | OCUL | OCULAR THERAPEUTIX, INC | Heier Jeffrey S. | CSO | S - Sale | $8.28 | -3,057 | 323.4K | -0.9% | -$25.3K | |
| D | 2026-01-06 | 2026-01-02 | OCUL | OCULAR THERAPEUTIX, INC | Heier Jeffrey S. | CSO | A - Grant | $0.00 | +79.1K | 326.4K | +32% | $0 |
| 2025-11-26 | 2025-11-24 | OCUL | OCULAR THERAPEUTIX, INC | Heier Jeffrey S. | CSO | S - Sale | $12.04 | -3,469 | 245.9K | -1% | -$41.8K | |
| 2025-10-06 | 2025-10-02 | OCUL | OCULAR THERAPEUTIX, INC | Heier Jeffrey S. | CSO | S - Sale | $11.04 | -10.5K | 249.4K | -4% | -$115.9K | |
| 2025-08-27 | 2025-08-25 | OCUL | OCULAR THERAPEUTIX, INC | Heier Jeffrey S. | CSO | S - Sale | $12.04 | -3,063 | 259.9K | -1% | -$36.9K | |
| 2025-05-27 | 2025-05-23 | OCUL | OCULAR THERAPEUTIX, INC | Heier Jeffrey S. | CSO | S - Sale | $7.18 | -3,024 | 263.0K | -1% | -$21.7K | |
| 2025-02-26 | 2025-02-24 | OCUL | OCULAR THERAPEUTIX, INC | Heier Jeffrey S. | CSO | S - Sale | $6.87 | -3,061 | 266.0K | -1% | -$21.0K | |
| 2024-11-27 | 2024-11-25 | OCUL | OCULAR THERAPEUTIX, INC | Heier Jeffrey S. | CSO | S - Sale | $9.01 | -2,948 | 269.1K | -1% | -$26.6K | |
| D | 2024-10-04 | 2024-10-02 | OCUL | OCULAR THERAPEUTIX, INC | Heier Jeffrey S. | CSO | A - Grant | $0.00 | +100.0K | 272.0K | +58% | $0 |
| D | 2023-06-16 | 2023-06-14 | OCUL | OCULAR THERAPEUTIX, INC | Heier Jeffrey S. | Dir | A - Grant | $0.00 | +12.0K | 59.9K | +25% | $0 |
| D | 2022-06-21 | 2022-06-16 | OCUL | OCULAR THERAPEUTIX, INC | Heier Jeffrey S. | Dir | A - Grant | $0.00 | +8,933 | 47.9K | +23% | $0 |
| 2022-05-16 | 2022-05-12 | OCUL | OCULAR THERAPEUTIX, INC | Heier Jeffrey S. | Dir | P - Purchase | $3.05 | +15.0K | 39.0K | +62% | +$45.8K |
Purchase Sale Sale after option exercise All abbreviations